Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine versus placebo in adults with glioblastoma multiforme
IRCT201512028612N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in glioblastoma (GBM) comparing Cyclosporine with Placebo (2 arms). Primary endpoints: Overall survival, Progression-free survival and 2 more. Started Jul 2014; status: completed.
02
Drugs
cyclosporine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on IRCT201512028612N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201512028612N3.